HOME >> MEDICINE >> NEWS
Animal studies indicate new approach for treating end-stage skin and kidney cancers

New Orleans, La., March 26, 2001 Advanced skin and end-stage kidney cancer patients may have a better chance of survival with drugs developed from a new synthetic enzyme that significantly improves the effectiveness of existing interleukin-2 (IL-2) cancer therapy, based on research presented today at the American Association for Cancer Research 92nd Annual Meeting.

In animal studies conducted by researchers at the Huntsman Cancer Institute in Salt Lake City, UT, and MetaPhore Pharmaceuticals in St. Louis, MO, the synthetic enzyme M40403 showed an ability to reverse the extreme blood-pressure drop that is a common side effect of high-dosage IL-2 cancer therapy. The research also showed that the compound enhances the anti-cancer properties of IL-2 therapy.

IL-2 immunotherapy, which works by activating natural killer (NK) cells that have the ability to recognize and destroy many types of tumors, is an approved treatment for inoperable metastatic melanoma and metastatic renal cell carcinoma. About 80,000 cases of melanoma and renal cell carcinoma are diagnosed in the U.S. each year.

IL-2 use is limited, however, by potentially life threatening side effects, including hypotension, particularly at the high-dosage level indicated for these end-stage cancers. A majority of patients undergoing high-dosage IL-2 treatment currently either require intensive care unit (ICU) intervention and/or are unable to complete the full course of treatment.

Reseachers administered the synthetic enzyme, which mimics the action of a natural enzyme, superoxide dismutase (SOD), as a co-therapy with IL-2 in several animal models of advanced cancer. Previous studies have confirmed that the synthetic enzyme effectively reproduces the free-radical fighting properties of the natural SOD enzyme, which has been found to be deficient in cancer states.

When in excess, free radicals particularly superoxide anions have been shown to deactivate a class of molecules, calle
'"/>

Contact: Punnie Donohue
pdonohue@kupperparker.com
314-290-2014
Kupper Parker Communications
25-Mar-2001


Page: 1 2 3 4

Related medicine news :

1. Animal study shows link between nicotine and atrial flutter
2. Animal studies show stem cells might make biological pacemaker
3. Animal study suggests safer immunization approach to Alzheimers
4. Animal model, new grant, propel UB researchers forward in search for tinnitus treatment
5. Animal model shows early promise for SARS vaccine
6. Understanding Alzheimers disease: Animal research points to new direction for therapy
7. Animal studies prove hormone replacement therapy improves memory, report Pitt researchers
8. Animal-based nutrients linked with higher risk of stomach and esophageal cancers
9. Animal study show that heat-sensitive liposome improves chemotherapy delivery to tumors
10. Animal model shows pain and tissue injury in newborns alters nerve circuitry and reaction to pain later in life
11. AVANT Atherosclerosis Vaccine Raises HDL, Reduces Atherosclerosis In Vaccinated Animals

Post Your Comments:
(Date:5/29/2015)... Mediaplanet has joined forces with Colorescience to ... Health is a cross-platform campaign with a national reach. ... York, Los Angeles, and Chicago, the campaign is expected ... will reach a national audience through one of Mediaplanet’s ... Health campaign and Colorescience, click here . ...
(Date:5/29/2015)... May 29, 2015 Healthpointe is ... with specialists, physical therapy, and injections , For ... back and/or lower back pain, Healthpointe has a ... for herniated discs, disc protrusions and other causes ... , Healthpointe’s team of renowned surgeons are now ...
(Date:5/29/2015)... Birmingham, AL (PRWEB) May 29, 2015 ... Beating Fibromyalgia and Chronic Fatigue Syndrome is now ... night. Callers can learn about natural ways to ... fatigue, low moods, poor sleep, and brain fog. ... free weekly Treating and Beating Fibromyalgia call in ...
(Date:5/29/2015)... Mirada, CA (PRWEB) May 29, 2015 ... bringing their expertise to the Los Angeles County ... Electromyography diagnostic procedures are now being offered at ... County, Orange County, and San Bernardino County. ... as motor neurons send electrical impulses throughout ...
(Date:5/29/2015)... Texas (PRWEB) May 29, 2015 ... the current state of the Naproxen industry.The report ... definitions, classifications, applications and industry chain structure. The ... the international markets including development trends, competitive landscape ... plans are discussed as well as manufacturing processes ...
Breaking Medicine News(10 mins):Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3Health News:Healthpointe Is Now Offering EMG and NCV Diagnostics at All Clinics throughout Southern California. 2Health News:Naproxen Market Analysis For Global & China Regions 2020 Research Forecasts 2
(Date:5/29/2015)... May 29, 2015 LifeNet Health plans to ... for 2015 to more than 160 people. ... for LifeNet Health,s innovative bio-implants, which are being made ... to be served. It also is a reflection of ... "The growth and success of LifeNet Health is ...
(Date:5/29/2015)... , May 29, 2015 ... the addition of the "Surgical/Operating Microscopes Market ... to 2020" report to their offering. ... surgical microscopes market is poised to reach $806.6 ... at a CAGR of 12.3% from 2015 to ...
(Date:5/29/2015)... -- Haemonetics Corporation (NYSE: HAE ) announced today that ... at the JMP Securities Life Sciences Conference in ... , 2015 at 11:30am Eastern time.  ... webcast at: http://wsw.com/webcast/jmp27/hae About ... global healthcare company dedicated to providing innovative blood management ...
Breaking Medicine Technology:LifeNet Health to add more than 160 jobs in 2015 2Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2
Cached News: